Cargando…
Reduced expression of TGF beta is associated with advanced disease in transitional cell carcinoma.
The gene structure and expression of the related peptide regulatory factors TGF beta 1 and TGF beta 2 were studied in a panel of seven urothelial carcinoma cell lines and 40 transitional cell carcinomas. The latter comprised 15 grade 1, 18 grade 2 and 5 grade 3 tumours and two cases of carcinoma in...
Autores principales: | Coombs, L. M., Pigott, D. A., Eydmann, M. E., Proctor, A. J., Knowles, M. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968278/ https://www.ncbi.nlm.nih.gov/pubmed/8439507 |
Ejemplares similares
-
Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
por: Coombs, L. M., et al.
Publicado: (1991) -
Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines.
por: Damstrup, L., et al.
Publicado: (1993) -
Transforming growth factor beta1 (TGF-beta1) is a preoperative prognostic indicator in advanced gastric carcinoma.
por: Nakamura, M., et al.
Publicado: (1998) -
Requirement of Podocalyxin in TGF-Beta Induced Epithelial Mesenchymal Transition
por: Meng, Xiaobo, et al.
Publicado: (2011) -
TGF-beta expression in the human colon: differential immunostaining along crypt epithelium.
por: Avery, A., et al.
Publicado: (1993)